Bliss GVS Pharma

156.25
-0.06
(-0.04%)
ann
There are new updates from the company1 day ago
Viewcross
right
Market Cap
1,646.40 Cr
EPS
8.02
PE Ratio
19.50
Dividend Yield
0.32 %
Industry
Healthcare
52 Week High
185.50
52 Week Low
103.01
PB Ratio
1.56
Debt to Equity
0.11
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,676.30
#1 4,02,200.50
35.07
#1 52,041.20
12.06
#1 10,980
-18.99
48.33
6,906.50
1,83,345.90
83.65
9,360.00
0.89
2,117
23.05
68.54
1,513.30
1,22,230.40
23.76
28,409.50
7.12
5,291
30.28
54.26
3,368.00
1,13,988.40
59.12
11,317.00
11.59
2,054
10.91
62.08
1,307.40
1,09,111.80
#1 19.63
33,741.20
12.36
5,725
21.14
54.13
1,001.00
1,00,724.00
21.57
22,573.80
13.82
3,977
-0.19
69.99
2,439.50
1,00,685.20
50.68
12,207.40
19.57
1,925
-10.91
59.65
1,980.90
90,466.80
27.51
22,192.10
#1 19.94
3,024
#1 112.49
53.08
34,735.00
73,809.50
52.20
6,409.15
10.80
1,417
27.83
64.97
1,191.30
69,190.90
20.01
31,378.10
17.55
3,366
-0.50
63.70
Forecast
Actual
Growth Rate
Revenue Growth
3.85 %
Net Income Growth
6.39 %
Cash Flow Change
344.33 %
ROE
-2.75 %
ROCE
-2.81 %
EBITDA Margin (Avg.)
27.85 %

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,214
1,301
Fixed Assets
234
225
305
143
146
242
234
282
379
370
419
Current Assets
417
471
566
690
694
770
765
777
697
812
827
Capital Work in Progress
0
9
4
1
47
0
2
22
3
8
21
Investments
0
0
0
0
0
0
0
2
8
4
126
Other Assets
428
527
714
717
712
786
840
803
768
832
0
Total Liabilities
662
762
1,023
860
905
1,027
1,077
1,109
1,157
1,214
1,301
Current Liabilities
243
267
437
299
207
231
204
233
193
160
172
Non Current Liabilities
68
50
33
13
38
46
45
29
46
51
37
Total Equity
352
446
553
548
660
750
828
847
917
1,003
1,050
Reserve & Surplus
327
402
476
526
636
725
798
808
874
957
1,040
Share Capital
10
10
10
10
10
10
10
10
10
11
11

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-34
23
30
-11
-22
0
-2
9
3
-1
Investing Activities
-30
-50
-249
48
-79
-40
-45
-103
-6
-133
Operating Activities
38
113
290
18
40
47
64
136
34
152
Financing Activities
-42
-40
-10
-76
17
-6
-21
-24
-25
-21

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
33.31 %
33.24 %
33.19 %
33.14 %
33.14 %
34.51 %
34.55 %
34.46 %
35.04 %
35.12 %
35.06 %
34.97 %
34.97 %
34.90 %
34.82 %
35.10 %
35.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.31 %
0.00 %
14.73 %
13.25 %
12.13 %
13.51 %
13.18 %
DIIs
6.72 %
6.72 %
6.67 %
6.66 %
6.66 %
6.65 %
6.64 %
6.63 %
6.63 %
6.62 %
6.61 %
6.59 %
6.59 %
6.58 %
6.57 %
6.55 %
6.55 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.45 %
26.90 %
27.59 %
28.26 %
30.37 %
30.15 %
30.57 %
30.74 %
30.00 %
30.10 %
29.17 %
30.78 %
31.71 %
32.84 %
34.57 %
32.93 %
32.63 %
Others
36.52 %
33.14 %
32.55 %
31.95 %
29.84 %
28.69 %
28.24 %
28.18 %
28.33 %
28.15 %
12.84 %
27.66 %
12.00 %
12.43 %
11.92 %
11.91 %
12.34 %
No of Share Holders
28,543
39,999
42,742
41,080
45,866
46,327
45,753
44,983
43,041
42,182
43,234
40,758
45,157
44,737
52,937
49,558
49,517

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.6 1 1 0.5 0.5 0.5 0.5 0.5 0.00
Dividend Yield (%) 0.00 0.31 0.56 0.99 0.51 0.65 0.71 0.44 0.42 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 118.75 156.25
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 117.21 118.75
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 163.13 148.40
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 130.70 124.42
25 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Jul 2024 129.20 119.20
19 Jul 2024 DIVIDEND Dividend
₹ 0.50 /share
18 Jul 2024 129.20 110.15
19 Jul 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Jul 2023 75.95 97.25
13 Jul 2023 DIVIDEND Dividend
₹ 0.50 /share
12 Jul 2023 83.76 85.06
28 Jun 2022 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Jun 2022 79.00 72.80
21 Jun 2022 DIVIDEND Dividend
₹ 0.50 /share
20 Jun 2022 79.00 72.90
14 Sept 2021 DIVIDEND Dividend
₹ 0.50 /share
13 Sept 2021 128.10 110.65

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20181 day ago
Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 20114 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS5 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2017-2018 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority5 days ago
Closure of Trading Window5 days ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 20119 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 12, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 12, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 12, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJun 06, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011May 26, 2025
Update On Legal ProceedingMay 23, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011May 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2025
Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019May 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2025
Integrated Filing (Financial)May 12, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 12, 2025
Intimation Of Book Closure In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 12, 2025
Corporate Action-Board approves DividendMay 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 12 2025.May 12, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesMay 12, 2025
Update on board meetingMay 07, 2025
Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended March 31 2025 And Recommendation Of Final Dividend If Any For The Year Ended March 31 2025.May 05, 2025
Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015- Pendency Of Litigation(S)/Dispute(S) May 03, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Intimation Of Change In Contact Details Of MUFG Intime India Private Limited Registrar And Share Transfer Agent Of The Company.Apr 22, 2025
Intimation Under Regulation 30 Of SEBI (LODR) Regulation 2015.Apr 15, 2025
Pendency Of Litigation(S)/Dispute(S)Apr 12, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 27, 2025
Closure of Trading WindowMar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 21, 2025
Integrated Filing (Financial)Jan 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 29, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024Jan 28, 2025
Board Meeting Outcome for Outcome Of Board MeetingJan 28, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 And Other Business Matters.Jan 21, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 16, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 07, 2025
Change Of Name Of Companys Registrar And Transfer Agent (RTA) From Link Intime India Private Limited To MUFG Intime India Private LimitedJan 02, 2025

Technical Indicators

RSI(14)
Neutral
66.49
ATR(14)
Less Volatile
6.54
STOCH(9,6)
Neutral
78.76
STOCH RSI(14)
Neutral
79.20
MACD(12,26)
Bullish
0.39
ADX(14)
Strong Trend
36.16
UO(9)
Bearish
41.36
ROC(12)
Uptrend And Accelerating
11.89
WillR(14)
Neutral
-20.07

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.07%
2
0.01%
0.01%